Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention — Stella

View on ClinicalTrials.gov

Recruiting

Back to Stroke trials

Trial locations(1 site)

Singapore

Tan Tock Seng Hospital, Singapore, Singapore

Key details

Sponsor

Tan Tock Seng Hospital

Collaborators

Rehabilitation Research Institute of Singapore (RRIS), Woodlands Health (WH)

Enrollment target

~500 participants

Started

January 2025

Primary completion

January 2027

Age range

50 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.